Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

Share Price is delayed by 15 minutes
Get Live Data
89.00    0.00 (0.00%)
Bid:
88.00
Ask:
90.00
Spread: 2.00 (2.273%)
Market Cap: £59.71m
EAH Live PriceLast checked at - London Stock Exchange

Intraday Eco Animal Share Chart

Director/PDMR Shareholding

21 Oct 2011 15:56

ECO ANIMAL HEALTH GROUP PLC ("ECO Animal" or "the Company")

Issue of Shares and Joint Share Ownership Awards

Issue of new Ordinary Shares

Eco Animal Health Group plc announces that the Company has, on 21 October 2011, issued and allotted a total of 784,000 new ordinary shares of 5p each in the Company ("Ordinary Shares"), representing 1.42 per cent of the enlarged issued share capital of the Company. Of this number, 764,000 were issued at a subscription price of 214p per ordinary share, this being the closing price of a share in the Company on 20 October 2011, pursuant to The ECO Animal Health Group Employees' Joint Share Ownership Plan ("the Plan"), and a further 20,000 were issued at a subscription price of £1.085 as a result of the exercise of options by an employee below board level.

Of the total number of shares issued, 625,000 shares have been issued into the respective joint beneficial ownership of (i) each of the participating executive Directors named below and (ii) the trustee of The ECO Animal Health Group Employees' Share Trust ("the Trust") upon and subject to the terms of joint ownership agreements ("JOAs") respectively entered into between the Director concerned, the Company and Appleby Trust (Jersey) Limited as trustee of the Trust ("the Trustee"). The subscription price has been paid by the Trust out of funds advanced to it by the Company.

Name of Director Jointly Owned Shares Awarded
Marc Loomes

Brett Clemo

Kevin Stockdale

Julia Trouse

225,000

150,000

125,000

125,000

The balance remaining of 159,000 shares have been issued to four other employees and the Trust upon and subject to JOA's on terms similar to those entered into by the executive directors on this occasion.

Application for admission to AIM of the 784,000 new Ordinary Shares has been made and it is expected that admission will happen on 27 October 2011.

The Directors of the Company will, following admission, hold beneficial interests as follows:

Name of Director No. of whole Shares in which the Director is interested No. of Shares in which the Director has an interest under the terms of a JOA or approved option scheme
Marc Loomes

Brett Clemo

Kevin Stockdale

Julia Trouse

-

4,519

8,051

3,291

1,158,750

460,000

390,000

546,100

Disclosure and Transparency Rules

In accordance with the FSA's Disclosure and Transparency Rules, the Company's issued share capital following the admission of the Ordinary Shares will comprise 55,030,451 ordinary shares of 5p with voting rights.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

Enquiries:

ECO Animal Health Group plc Kevin Stockdale, Finance tel: 0208 336 6186
Director

Peter Lawrence, Chairman

tel: 0208 336 6190

Cenkos Securites Ltd (Nominated Adviser) Elizabeth Bowman tel: 0207 397 8928

**********************************************

Copyright Business Wire 2011

Date   Source Headline
4th Jun 20267:00 amRNSRenewal of revolving credit facility
14th Apr 20267:00 amRNSAppointment of Head of Business Development
31st Mar 20267:00 amRNSBoard Change
19th Mar 20267:00 amRNSFull Year Trading Update
11th Mar 20267:00 amRNSECOVAXXIN® MG favourable USDA safety assessment
11th Mar 20267:00 amRNSECOVAXXIN®?MG favourable USDA safety assessment
5th Mar 20264:19 pmRNSBlock Listing Return
26th Feb 20267:00 amRNSEU launch plans for ECOVAXXIN® MS
19th Jan 20261:50 pmRNSHolding(s) in Company
22nd Dec 20257:00 amRNSECOVAXXIN® MS EU marketing authorisation granted
22nd Dec 20257:00 amRNSECOVAXXIN® MS EU marketing authorisation granted
18th Dec 20257:00 amRNSExercise of Share Options by Director
9th Dec 20255:57 pmRNSHolding(s) in Company
4th Dec 20252:10 pmRNSDirector/PDMR Shareholding
1st Dec 20257:00 amRNSResults for the six months ended 30 September 2025
20th Nov 20259:47 amRNSReplacement: Notice of Results
20th Nov 20257:00 amRNSNotice of Results
10th Nov 20257:00 amRNSEMA Positive Opinion Received for ECOVAXXIN® MS
1st Oct 20257:00 amRNS-RHead of Global R&D
25th Sep 20253:15 pmRNSResult of AGM
25th Sep 20257:00 amRNSAGM Trading Update and Notice of Interim Results
1st Sep 20257:00 amRNSAppointment of Joint Broker
29th Aug 20257:00 amRNSShare Awards to Executive Directors
28th Aug 20257:48 amRNSPosting of Annual Report and Notice of AGM
21st Aug 202512:29 pmRNSResult of General Meeting
13th Aug 20257:00 amRNSBlock Listing Return
6th Aug 20255:09 pmRNSHolding(s) in Company
17th Jul 20257:00 amRNSHolding(s) in Company
15th Jul 20251:00 pmRNSDirector/PDMR Shareholding
14th Jul 20257:00 amRNSResults for the year ended 31 March 2025
8th Jul 20254:10 pmRNSNotice of General Meeting and Notice of Results
2nd May 20257:00 amRNSHolding(s) in Company
28th Apr 20257:00 amRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSTrading Update
13th Mar 20257:00 amRNSR&D Day
3rd Mar 20257:00 amRNSSubmission of Marketing Authorisation Application
24th Feb 20254:08 pmRNSHolding(s) in Company
19th Feb 20257:00 amRNSDisposal of non-core assets
18th Feb 20257:00 amRNSBlock listing Interim Review
13th Feb 20257:00 amRNSNotice of R&D Day
31st Jan 20257:00 amRNSBoard Changes
20th Dec 20247:00 amRNSHolding(s) in Company
16th Dec 20247:00 amRNSHolding(s) in Company
2nd Dec 202412:30 pmRNSShare Purchase by Executive Director
28th Nov 20247:00 amRNSResults for the Six Months Ended 30 September 2024
28th Oct 202412:57 pmRNSShare Awards to Executive Directors
22nd Oct 202411:00 amRNSEBT Share Purchase
21st Oct 20247:00 amRNSEBT Share Purchase
14th Oct 202411:07 amRNSEBT Share Purchase
9th Oct 20247:00 amRNSIssue of Equity and TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.